Efficacy and Safety of Generic Sofosbuvir Plus Daclatasvir and Sofosbuvir/Velpatasvir in HCV Genotype 3-Infected Patients: Real-World Outcomes From Pakistan-Reference-Cited by-同舟云学术

Efficacy and Safety of Generic Sofosbuvir Plus Daclatasvir and Sofosbuvir/Velpatasvir in HCV Genotype 3-Infected Patients: Real-World Outcomes From Pakistan

Published:2020-09-02 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Mushtaq Saima,Akhter Tayyab Saeed,Khan Amjad,Sohail Aamir,Khan Arshad,Manzoor Sobia

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference48 articles.

1. The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses;Al Kanaani;R. Soc. Open Sci.,2018

2. Virological response to conventional interferon therapy combined with ribavirin against various HCV genotypes in Khyber Pakhtunkhwa, Pakistan;Ali;Asian Pacific J. Cancer Prev.,2016

3. Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials;Arias;Antivir. Ther.,2017

4. Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 US Veterans;Backus;Alimentary Pharmacol. Ther.,2015

5. Status of direct-acting antiviral therapy for hepatitis C virus infection and remaining challenges;Baumert;Gastroenterology,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-08

2. Benthic Macroinvertebrate Communities as Indicator of the Water Quality of a Suburban Stream in the Littoral Region of Cameroon;Pollutants;2024-05-07

3. Hepatitis C Elimination. Are we on course for 2030?;Annals of King Edward Medical University;2024-03-30

4. An Update on National Consensus Practice Guidelines for the Treatment of Hepatitis C & Literature Review in Epidemiology of Hepatitis C in Pakistan - 2022;Journal of Rawalpindi Medical College;2024-02-01

5. HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocol;BMC Public Health;2023-12-18